Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2020	$ 274,282	$ 3	$ 315,288	$ 33	$ (41,042)
Beginning balance, shares at Dec. 31, 2020		32,485,784
Issuance of common stock upon exercise of common stock options and vesting of restricted stock units	327		327
Issuance of common stock upon exercise of common stock options and vesting of restricted stock units, Shares		266,653
Issuance of common stock under employee stock purchase plan	364		364
Issuance of common stock under employee stock purchase plan, shares		26,640
Proceeds from initial public offering, net of underwriters' discounts and commissions and issuance costs	96,762	$ 1	96,761
Proceeds from initial public offering, net of underwriters' discounts and commissions and issuance costs, Shares		4,600,000
Stock-based compensation	4,623		4,623
Unrealized loss on available-for-sale securities	(421)			(421)
Net loss	(54,853)				(54,853)
Ending balance at Dec. 31, 2021	321,084	$ 4	417,363	(388)	(95,895)
Ending balance, shares at Dec. 31, 2021		37,379,077
Issuance of common stock upon exercise of common stock options	$ 309		309
Issuance of common stock upon exercise of common stock options, shares	300,038	419,949
Issuance of common stock under employee stock purchase plan	$ 345		345
Issuance of common stock under employee stock purchase plan, shares		78,361
Stock-based compensation	10,606		10,606
Unrealized loss on available-for-sale securities	(1,568)			(1,568)
Net loss	(95,639)				(95,639)
Ending balance at Dec. 31, 2022	$ 235,137	$ 4	$ 428,623	$ (1,956)	$ (191,534)
Ending balance, shares at Dec. 31, 2022		37,877,387